اختبار: العلاج بالنظائر المشعة A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Polycythemia vera Dyspnea in lung Ca Pain in bony metastases Medullary thyroid carcinoma None 2. Which of the following time is advised for patients treated with 1-131 to delay conception after treatment? 2 months 6 months 4 months 1 month None 3. Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy? Sm-153 Sr-89 Ra-223 P-32 None 4. Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is: Thyroid carcinoma Hypothyroidism Thyroiditis Hyperthyroidism None 5. Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are: Methimazole and Propylthiouracil Metronidazole and Propylthiouracil Metronidazole and Propranolol Methimazole and Propranolol None 6. Which of the following property of radiation is principally used in the treatment of tumors? Biologic effect Fluorescent effect Photographic effect Chemical effect None 7. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Radioimmunotherapy. Radiochemotherapy. Antibody therapy. Radiation therapy. None 8. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Bruising Fever Anemia Arrhythmia None 9. Transient increase in tracer uptake in responding metastases in the early months after chemotherapy/hormone therapy for breast and prostate cancer is called: Super phenomenon. Flare scan. Super scan. Flare phenomenon. None 10. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: After 3 months. After 6 months. With the birth of another child. Never. None 1 out of 10 Time's upTime is Up! بواسطة ناصر المطيري|2021-09-20T14:25:06+03:00أبريل 26th, 2021|العلاج بالنظائر المشعة|لا توجد تعليقات شارك هذه الصفحة, واترك رأيك حول الموضوع باستخدام وسيلة التواصل التي تناسبك FacebookXLinkedInWhatsAppPinterestEmail عن: ناصر المطيري كبير أخصائيي الطب النووي في مستشفى حفر الباطن المركزي و مؤسس موقع نيوكليرمد. اضف تعليقا إلغاء الردتعليق أعلمني بمتابعة التعليقات بواسطة البريد الإلكتروني. أعلمني بالمواضيع الجديدة بواسطة البريد الإلكتروني. Δ
اضف تعليقا